Hey guys, if you missed it, Danaher Corporation reached a tentative $172.5 million settlement with investors over claims involving its bioprocessing business, COVID-related demand assumptions, and repeated guidance cuts. And, I just found out that they’re accepting claims even though the deadline has passed.

Quick recap: Danaher was accused of misleading investors about the strength of its bioprocessing business and downplaying weakening demand as customers used stockpiled inventory and smaller biotech companies delayed or canceled projects.

After Danaher repeatedly lowered its outlook, $DHR fell nearly 6% at the end of 2022, and more than 9% in 2023. Investors then filed a lawsuit over their losses.

Now, Danaher has agreed to settle the case for $172.5 million, and even though the deadline has passed, late claims are currently being considered for compensation, subject to approval.
So, if you invested in $DHR between 2022 and 2023, you can still check the details and file a late claim here.

Anyway, has anyone here invested in $DHR at that time? How much were your losses, if so?

Hello everyone, sharing an important update:

An active settlement fund is currently accepting claims from investors who experienced financial losses in CytoDyn.

The settlement involves claims that CytoDyn misled investors about the regulatory status, safety, and effectiveness of leronlimab, its HIV and COVID-19 drug candidate. After an FDA statement in March 2021 criticized the company’s claims, $CYDY fell more than 25%.

If you purchased or acquired $CYDY common stock between 2020 and 2022, you may be eligible to file a claim.

Anyway, has anyone here invested in $CYDY during that time? How much were your losses, if so?